New report published by Global Info Research which offers insights on the global Epinephrine Auto-Injectors market.
Auto-injector is a medical device designed to deliver a dose of a particular drug.
Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-epinephrine-auto-injectors-market_p80154.html
Global Epinephrine Auto-Injectors Market: Forecast by Type / Application / Region
The major players in global Auto-Injectors market include: Mylan, BD, Johnson & Johnson, Amgen Inc., Eli Lilly, Biogen Idec, Bayer, Meridian (Pfizer), Ypsomed Holding, Kaleo, Inc., Owen Mumford, Antares Pharma, Inc., Medeca Pharma AB.
On the basis of product, the Auto-Injectors market is primarily split into: Disposable Auto-Injectors, Reusable Auto-Injectors.
On the basis on the end users/applications covers: Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others.
In the last several years, global market of Auto-Injectors developed rapidly, with an average growth rate of 5.04%. In 2017, global revenue of Auto-Injectors is nearly 1660 Million USD; the actual sales are about 17 million units.
Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery.
The global average price of Auto-Injectors is in the increasing trend from 2013-2016, Auto-injectors manufacturers are introducing generic versions in order to reduce the overall cost of the device. In order to better serve anaphylaxis patients with epinephrine at an affordable cost, Mylan N.V. has implemented the decision of introducing the generic version of Epipen at half the price. The initial pack of two was sold at US$ 600 till December 2016 which will be sold at US$ 300 from January 2017. This has increased the affordability of insured as well as non-insured patients to opt for Epipen.
The classification of Auto-Injectors includes reusable Auto-Injectors and disposable Auto-Injectors, and the proportion of disposable Auto-Injectors in 2017 is about 62.7%, and the proportion is in increasing trend from 2013 to 2017.
Auto-injectors are pen like devices used to deliver a fixed dose of drug to patients and are intended for self-administration. Auto-injectors are gradually becoming the gold-standard in the treatment of various indications like anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. The most proportion of Auto-Injectors is used for Anaphylaxis, and the proportion in 2017 is 56.9%.
North America is the largest consumption place, with a consumption market share nearly 59.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. China is also an important sales region.
Market competition is not intense. Mylan, BD, Johnson & Johnson, Amgen Inc., etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-epinephrine-auto-injectors-market_p80154.html
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Related Information:
United States Epinephrine Auto-Injectors Market 2018 Forecast to 2023
Europe Epinephrine Auto-Injectors Market 2018 Forecast to 2023
North America Epinephrine Auto-Injectors Market 2018 Forecast to 2023
Asia-Pacific Epinephrine Auto-Injectors Market 2018 Forecast to 2023
China Epinephrine Auto-Injectors Market 2018 Forecast to 2023
EMEA Epinephrine Auto-Injectors Market 2018 Forecast to 2023
Global Epinephrine Auto-Injectors Market 2018 Forecast to 2023
Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com
